Form of Convertible Redeemable Promissory Note issued by Adhera Therapeutics, Inc. to select accredited investors on March 15, 2022
Contract Categories:
Business Finance
- Note Agreements
EX-4.21 2 ex4-21.htm
Exhibit 4.21
